Gottlieb, McClellan push for FDA regulatory reforms
The decision by lawmakers to drop regulatory reforms of dietary supplements, cosmetics and diagnostic tests from the recent FDA user fee reauthorization constitutes a “profound missed opportunity” to strengthen the agency’s ability to protect consumers, former FDA Commissioners Scott Gottlieb and Mark McClellan wrote in a JAMA piece published Thursday.